MacroGenics Inc
NASDAQ:MGNX
MacroGenics Inc
NASDAQ:MGNX
Price:
1.73
USD
-1.14%
Market Closed
Market Cap:
$109.4m
Balance Sheet
Balance Sheet Decomposition
MacroGenics Inc
MacroGenics Inc
Balance Sheet Decomposition is not available for
MacroGenics Inc
MacroGenics Inc
Balance Sheet
MacroGenics Inc
MacroGenics Inc
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
55
|
48
|
117
|
158
|
196
|
84
|
212
|
220
|
127
|
181
|
124
|
109
|
101
|
183
|
|
| Cash Equivalents |
55
|
48
|
117
|
158
|
196
|
84
|
212
|
220
|
127
|
181
|
124
|
109
|
101
|
183
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
143
|
193
|
93
|
13
|
89
|
91
|
120
|
46
|
129
|
19
|
|
| Total Receivables |
3
|
2
|
2
|
3
|
1
|
3
|
14
|
30
|
13
|
23
|
10
|
56
|
10
|
4
|
|
| Accounts Receivables |
3
|
2
|
2
|
3
|
1
|
3
|
14
|
30
|
13
|
23
|
10
|
56
|
10
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
2
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
4
|
2
|
4
|
4
|
7
|
11
|
17
|
21
|
10
|
10
|
12
|
|
| Total Current Assets |
59
|
50
|
120
|
165
|
342
|
284
|
322
|
269
|
240
|
313
|
280
|
222
|
251
|
217
|
|
| PP&E Net |
3
|
3
|
5
|
7
|
15
|
18
|
50
|
57
|
48
|
61
|
54
|
57
|
46
|
43
|
|
| PP&E Gross |
3
|
3
|
5
|
7
|
15
|
18
|
50
|
57
|
48
|
61
|
54
|
57
|
46
|
43
|
|
| Accumulated Depreciation |
13
|
14
|
16
|
17
|
20
|
26
|
29
|
38
|
50
|
62
|
73
|
84
|
88
|
89
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
2
|
2
|
1
|
2
|
6
|
25
|
5
|
1
|
1
|
1
|
2
|
|
| Total Assets |
63
N/A
|
54
-14%
|
126
+134%
|
174
+38%
|
359
+107%
|
311
-13%
|
374
+20%
|
332
-11%
|
313
-6%
|
379
+21%
|
335
-11%
|
281
-16%
|
298
+6%
|
262
-12%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
11
|
4
|
3
|
2
|
3
|
4
|
3
|
4
|
4
|
8
|
16
|
5
|
6
|
5
|
|
| Accrued Liabilities |
1
|
1
|
4
|
8
|
12
|
16
|
39
|
33
|
30
|
38
|
38
|
34
|
28
|
34
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
32
|
24
|
21
|
16
|
8
|
6
|
8
|
23
|
11
|
5
|
21
|
10
|
22
|
16
|
|
| Total Current Liabilities |
44
|
30
|
29
|
27
|
24
|
27
|
50
|
60
|
45
|
51
|
75
|
49
|
56
|
56
|
|
| Long-Term Debt |
10
|
9
|
0
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
26
|
23
|
18
|
19
|
19
|
15
|
25
|
29
|
37
|
32
|
21
|
90
|
90
|
90
|
|
| Total Liabilities |
80
N/A
|
62
-23%
|
47
-24%
|
53
+12%
|
46
-13%
|
43
-7%
|
75
+76%
|
89
+20%
|
82
-8%
|
83
+1%
|
96
+15%
|
139
+45%
|
146
+5%
|
146
0%
|
|
| Equity | |||||||||||||||
| Common Stock |
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
184
|
176
|
176
|
214
|
234
|
293
|
312
|
490
|
642
|
772
|
974
|
1 094
|
1 103
|
1 170
|
|
| Additional Paid In Capital |
163
|
164
|
255
|
335
|
547
|
561
|
611
|
733
|
872
|
1 067
|
1 213
|
1 235
|
1 255
|
1 285
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
18
N/A
|
8
+53%
|
79
N/A
|
121
+54%
|
313
+158%
|
269
-14%
|
299
+11%
|
243
-19%
|
231
-5%
|
296
+28%
|
240
-19%
|
142
-41%
|
153
+7%
|
116
-24%
|
|
| Total Liabilities & Equity |
63
N/A
|
54
-14%
|
126
+134%
|
174
+38%
|
359
+107%
|
311
-13%
|
374
+20%
|
332
-11%
|
313
-6%
|
379
+21%
|
335
-11%
|
281
-16%
|
298
+6%
|
262
-12%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
24
|
24
|
25
|
28
|
34
|
35
|
37
|
42
|
49
|
56
|
61
|
62
|
62
|
63
|
|
Switch to:
Switch to:
See Also
Discover More
